The Cancer Tumor Profiling Market is expected to reach USD 31.99 Billion by 2027. This market’s growth is attributed to the increasing use of biomarkers in cancer profiling, eventually rising adoption of proteomic methods for biomarker research, thus helping to increase the drug development process over the estimated period. The growing demand for personalized medicine and the rise in cancer incidence across the globe is augmenting the demand for the industry. According to the World Health Organization (WHO), Lung and Breast cancer is a common type of cancer, with around 2.09 million cases every year. The growing demand for cancer tumor profiling is driving the market for the estimated period.
The rise in the adoption of the cancer tumor profiling methods by oncologists is seen to drive the market because of the efficacy of cancer tumor profiling for diagnosis at the early stage of cancer, which is one factor in boosting the market growth. However, technical issues with sample collection and storage remain one of the factors that hinder the growth of the market for the forecast period.
To know more about the report @ https://www.emergenresearch.com/industry-report/cancer-tumor-profiling-market
Emergen Research has recently published a detailed report on the global Cancer Tumor Profiling Market formulated through extensive primary and secondary research. The report offers in-depth knowledge and analysis of the Cancer Tumor Profiling Market through verified and validated data curated to offer accurate insights. The report also offers a region wise and country wise analysis of the Cancer Tumor Profiling Market and contains a detailed analysis of the key elements influencing the growth of the market in the region. The research study also contains historical, current, and forecast estimations for each sector, segment, sub-segment, and regions.
Some major companies in the global market report include Caris Life Sciences, Foundation Medicine, GenomeDX, Genomic Health, Guardant Health, Helomics Corporation, HTG Molecular Diagnostics, Inc., Nanostring Technologies, Neogenomics Inc., Oxford Gene Technology, Qiagen N.V., Ribomed Biotechnologies Inc., among others.
Get a sample of the report @ https://www.emergenresearch.com/request-sample/50
Emergen Research have segmented the Cancer Tumor Profiling Market on the basis of technique type, technology, application, and region:
Technique Type Outlook (Revenue, USD Billion; 2017-2027)
Genomics
Epigenetics
Metabolomics
Proteomics
Technology Outlook (Revenue, USD Billion; 2017-2027)
Immunoassays
In Situ Hybridization
Fluorescence In Situ Hybridization (FISH)
Chromogenic In Situ Hybridization (CISH)
Microarray
Polymerase Chain Reaction (PCR)
Sequencing Technologies
Next Generation Sequencing(NGS)
Pyro Sequencing
Sanger Sequencing
Other Technologies
Application Outlook (Revenue, USD Billion; 2017-2027)
Research Application
Biomarker Discovery
Personalized Cancer Medicine
Clinical Application
Oncological Diagnostics
Prognostics
Monitoring and Treatment
Screening
Key insights presented in the report:
Market revenue shares by major business players, by type, by application, and market scope of global Cancer Tumor Profiling market
Sales revenue by key players and new entrants
Competitive analysis of key players, including aspects such as company overview, product or services specification, vendors, and buyers
Recent mergers, acquisitions, product launches, recent investments, and joint ventures
Regional analysis to provide insight into recent trends and opportunities
The report also offers regional level analysis and market estimation for the regions: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Regional Outlook of Cancer Tumor Profiling Market:
North America
U.S.
Canada
Mexico
Europe
Germany
U.K.
Italy
France
BENELUX
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
U.A.E.
South Africa
Rest of MEA
Thank you for reading the research report. To get more information about the customized report and customization plan, kindly connect to us and we will provide you with the well-suited customized report.
About Us:
At Emergen Research, we believe in advancing with technology. We are growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
